The EU is not ready to establish a regulatory framework for endocrine disruptors. Following reservations voiced by industry experts and the scientific community, the European Commission has therefore decided to postpone the adoption of a scientific definition for these substances, which can alter hormonal regulation in the body. Instead, the Commission will launch a public consultation (in January) as well as an impact assessment (during the first half of this year) on the issue of identifying and assessing endocrine disruptors.

The adoption of an operational definition for endocrine disruptors had originally been planned for the end of 2013 by Regulations 528/2012 on biocidal products and 1107/2009 on athe placing of plant protection products on the market .

Asked about the change of plan, the spokesperson for Environment Commissioner Janez Potocnik recalled several issues raised by the industry and the scientific community, and specifically by the Commission's Chief Scientific Advisor Anne Glover and the signatories of the 'Berlaymont declaration'. According to the spokesperson, contrary to the original plans, the future College of Commissioners will establish the criteria for identifying and evaluating endocrine disruptors by autumn this year. The regulatory framework will be drafted based on these criteria at a later date.

MEP Michele Rivasi (Greens-EFA, France) believes that this delay marks a step in the wrong direction. "This clearly means that all the clear...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT